Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Hallucinogen-Assisted Psychotherapy for Trauma Disorders: A Bionian Lens.
Journal: Psychodynamic psychiatry
Published: June 16, 2026
Therapeutic and Structural Dimensions in Psychiatric Prescribing: Bridging Psychedelics and Antidepressants.
Journal: Harvard review of psychiatry
Published: March 17, 2025
Beyond psychedelics: set and setting in general psychiatric practice.
Journal: International review of psychiatry (Abingdon, England)
Published: February 21, 2025
The Long Road Toward Equitable MDMA Treatment in the United States.
Journal: The Journal of clinical psychiatry
Published: May 30, 2024
New evidence for flexible psilocybin dosing in patients with treatment-resistant depression.
Journal: Med (New York, N.Y.)
Published: January 21, 2024
Innovations in group-based psilocybin-assisted therapy of major depression in patients with cancer.
Journal: Cancer
Published: December 18, 2023
Assessing potential of psilocybin for depressive disorders.
Journal: Expert opinion on investigational drugs
Published: October 23, 2023
Factors associated with daily use of benzodiazepines/tranquilizers and opioids among people who use drugs.
Journal: The American journal on addictions
Published: April 04, 2023
Patients With Schizophrenia-Spectrum Disorders as Vulnerable Populations in an Age of Misinformation: A Case Report of Ivermectin-Related Liver Failure.
Journal: Journal of the Academy of Consultation-Liaison Psychiatry
Published: July 22, 2022
Harm reduction behaviors are associated with carrying naloxone among patients on methadone treatment.
Journal: Harm reduction journal
Published: May 25, 2022
Open-label dose-extending placebos for opioid use disorder: a protocol for a randomised controlled clinical trial with methadone treatment.
Journal: BMJ open
Published: June 24, 2019
Showing 1-11 of 11
Last Updated: 09/26/2026